NewEdge Wealth’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $515K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $3.22M | Buy |
|
|||||
|
2024
Q4 | $3.13M | Sell |
|
|||||
|
2024
Q3 | $4.23M | Buy |
|
|||||
|
2024
Q2 | $4.21M | Buy |
|
|||||
|
2024
Q1 | $4.63M | Buy |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $3.31M | Buy |
|
|||||
|
2023
Q2 | $3.23M | Buy |
|
|||||
|
2023
Q1 | $2.98M | Buy |
|
|||||
|
2022
Q4 | $3.09M | Buy |
|
|||||
|
2022
Q3 | $2.78M | Buy |
|
|||||
|
2022
Q2 | $2.83M | Buy |
|
|||||
|
2022
Q1 | $2.25M | Buy |
|
|||||
|
2021
Q4 | $2.48M | Buy |
|
|||||
|
2021
Q3 | $2.64M | Buy |
|
|||||
|
2021
Q2 | $2.04M | Buy |
|
|||||
|
2021
Q1 | $1.55M | Buy |
|
|||||
|
2020
Q4 | $221K | Buy |
|